Aminophylline for improving acute kidney injury in pediatric patients: A systematic review and meta-analysis

Saad Alsaadoun1, Faisal Rustom2, Hanan Abu Hassan3

  • 1Department of Pediatric, Division of Pediatric Nephrology, Security Forces Hospital, Riyadh 13225, Saudi Arabia.

Insights

Aminophylline may help reduce serum creatinine levels in pediatric patients with acute kidney injury (AKI). However, it does not significantly impact urine output, AKI incidence, or mortality rates in children.

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Acute kidney injury (AKI) is a significant contributor to morbidity and mortality in children.
  • The role of aminophylline in preventing or treating pediatric AKI remains unclear.
  • This meta-analysis investigates the efficacy of aminophylline in pediatric AKI cases.

Purpose of the Study:

  • To assess the effectiveness of aminophylline in pediatric patients diagnosed with AKI.
  • To determine if aminophylline administration impacts key renal function markers and patient outcomes.
  • To provide evidence for clinical decision-making regarding aminophylline use in pediatric AKI.

Main Methods:

  • A systematic literature search was conducted across six major databases (PubMed, EMBASE, Scopus, Cochrane Library, Google Scholar) from January 1995 to May 2019.
  • Data from seven identified studies involving aminophylline use in children with AKI were analyzed.
  • Risk ratios and standard mean differences were calculated using a random effects model for meta-analysis.

Main Results:

  • Single-arm studies showed no significant changes in serum creatinine clearance, urine output, or blood urea nitrogen levels post-aminophylline administration.
  • However, double-arm studies revealed that aminophylline significantly reduced serum creatinine levels compared to control groups (mean diff = -34).
  • No statistically significant effects were observed for aminophylline on urine output, AKI incidence, or mortality rates.

Conclusions:

  • Aminophylline administration in pediatric AKI patients appears to lower serum creatinine levels.
  • The treatment did not demonstrate significant adverse effects or impact on AKI incidence, urine output, or mortality.
  • Further large-scale, well-designed randomized controlled trials are necessary to confirm these findings and explore long-term effects.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
151
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
161
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
331
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
97
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
222